Revance Therapeutics shares owned by Graham Capital Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Graham Capital Management
from 13F filings
Historical chart of Graham Capital Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Revance Therapeutics by Graham Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $1.2M | 400k | 3.04 |
2024-09-30 | $2.2M | 426k | 5.19 |
2024-06-30 | $1.1M | 417k | 2.57 |
2023-09-30 | $122k | 11k | 11.47 |
2023-06-30 | $817k | 32k | 25.31 |
2022-03-31 | $390k | 20k | 19.47 |